Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy
Neuromuscular Disorders2012Vol. 22(12), pp. 1040–1045
Citations Over TimeTop 11% of 2012 papers
Related Papers
- → Novel Approaches to Corticosteroid Treatment in Duchenne Muscular Dystrophy(2012)65 cited
- → SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells(2017)34 cited
- → The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy(2020)30 cited
- → Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy(2009)9 cited
- → Potential Mechanisms for Prolonged Loss of Ambulation with Deflazacort in Duchenne Muscular Dystrophy - Tolerability Profile and Effects on Growth (P5.059)(2016)